Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/28/2003US6638505 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer
10/28/2003US6638498 A compound, comprising a molecularly imprinted polymer featuring at least one functional monomer selected from the vinyl hydroxypyridine; monomers selected from 4-vinylbenzamide and N-alkyl or N,N-dialkyl derivatives
10/28/2003US6638497 Method of manufacturing quat-containing compositions with improved transportation efficiency and/or processing properties
10/28/2003US6638296 Hemostasis pad and method
10/28/2003CA2342309C New solid dose form of nanoparticulate naproxen
10/28/2003CA2283939C Non-antigenic branched polymer conjugates
10/28/2003CA2280185C Novel salicylic acid derivatives and their use in cosmetic or dermatological compositions
10/28/2003CA2269897C Aminophenol derivatives and their use in cosmetics
10/28/2003CA2254521C New pyrrol derivatives, their method of preparation and pharmaceutical compositions containing these derivatives
10/28/2003CA2253796C Inhibition of matrix metalloproteases by acetylene containing compounds
10/28/2003CA2252701C Halo-substituted protein kinase c inhibitors
10/28/2003CA2249786C Difluoro statone analogs
10/28/2003CA2228254C Process for producing erythromycin derivatives
10/28/2003CA2227238C Method of treating colonic adenomas
10/28/2003CA2221114C Atherosclerosis treatment
10/28/2003CA2213099C S-(+)-adenosylmethionine and 3'-azido-2',3'-dideoxy-nucleoside complexes as potent inhibitors of hiv-replication
10/28/2003CA2209711C Plaster containing estradiol
10/28/2003CA2139505C Precipitation of one or more active compounds in situ
10/28/2003CA2105486C Therapeutic nucleosides
10/28/2003CA2101179C Phenylimidazolidine derivatives, their preparation and their use
10/28/2003CA2037116C Hexahydrobenz ¢cd! indoles
10/23/2003WO2003087832A2 Diagnosis of carcinoma using raigi polypeptides
10/23/2003WO2003087818A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
10/23/2003WO2003087769A2 Method for identifying modulators of ion channels
10/23/2003WO2003087411A1 Method to inhibit cell growth using oligonucleotides
10/23/2003WO2003087408A2 Schizophrenia associated genes
10/23/2003WO2003087399A1 Nad)p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes
10/23/2003WO2003087389A2 Biologic modulations with nanoparticles
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087369A2 Ribozyme capable of specifically cleaving mmp-13
10/23/2003WO2003087368A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003WO2003087367A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003WO2003087344A1 New strains capable of producing conjugated linoleic acid, capsulated composition comprising them, and the preparation methods thereof
10/23/2003WO2003087339A2 Spray freeze dry of compositions for pulmonary administration
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087323A2 Biologic modulations with nanoparticles
10/23/2003WO2003087316A2 Novel derivatives of carnosic acid
10/23/2003WO2003087308A2 Use of interleukin-24 to treat ovarian cancer
10/23/2003WO2003087307A2 Use of interleukin-19 to treat cervical cancer
10/23/2003WO2003087304A2 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003WO2003087298A2 Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
10/23/2003WO2003087196A1 Thermogelling oligopeptide polymers
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087164A1 Iron dextrin compounds for the treatment of iron deficiency anaemia
10/23/2003WO2003087126A2 Heteroclitic analogs and related methods
10/23/2003WO2003087121A1 Branched polyamine steroid derivatives
10/23/2003WO2003087120A1 Estrone derivative and process for producing the same
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087106A1 Derivatives of 2,2,4-trisubstituted tetrahydrofuran as antifungal agents
10/23/2003WO2003087105A1 INHIBITORS OF SERINE AND METALLO-ß-LACTAMASES
10/23/2003WO2003087104A1 Heterocyclic compounds
10/23/2003WO2003087103A1 Thienyl compounds
10/23/2003WO2003087102A1 Furyl compounds
10/23/2003WO2003087101A1 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles
10/23/2003WO2003087100A1 Process for preparing acid salts of gemifloxacin
10/23/2003WO2003087099A1 Imidazo-pyridine derivatives as ligands for gaba receptors
10/23/2003WO2003087098A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
10/23/2003WO2003087097A1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug
10/23/2003WO2003087096A1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament
10/23/2003WO2003087095A1 Quinolinone derivatives
10/23/2003WO2003087093A1 Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
10/23/2003WO2003087090A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003WO2003087089A1 Piperidine derivatives having ccr3 antagonism
10/23/2003WO2003087088A2 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087086A2 Substituted indoles
10/23/2003WO2003087085A1 Heterocyclic amide derivatives as cytokine inhibitors
10/23/2003WO2003087080A1 Medicinal composition for improving angiotension-regulating function of blood vessel endothelium
10/23/2003WO2003087074A1 Phenol compound, process for producing the same, and intermediate therefor
10/23/2003WO2003087073A1 Estrogen receptor modulators
10/23/2003WO2003087065A1 Inhibitors of glycinamide ribonucleotide transformylase
10/23/2003WO2003087064A1 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
10/23/2003WO2003087062A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
10/23/2003WO2003087061A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003087060A1 Fredericamycin derivatives
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087055A1 Improved cc-1065 analog synthesis
10/23/2003WO2003087050A2 Novel perindopril salt and pharmaceutical compositions containing same
10/23/2003WO2003087042A1 Occlusive composition comprising a poly (2-cyanoacrylate) monomer
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087038A1 Crystal forms of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003087035A1 2,5-bis-diamine-'1,4! benzoquinone derivatives for the treatment of alzheimer's disease a process for their preparation and intermediates therefor
10/23/2003WO2003087026A1 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003WO2003087021A2 Nanoparticle delivery systems and methods of use thereof
10/23/2003WO2003087019A1 Hyaluronic acid modification product
10/23/2003WO2003086563A2 Diabetes imaging probes
10/23/2003WO2003086516A1 Therapeutic dry powder preparation
10/23/2003WO2003086497A1 Drug eluting vascular stent and method of treating hyperproliferative vascular disease
10/23/2003WO2003086468A1 Aqueous dispersible steryl ester compositions
10/23/2003WO2003086467A1 Cancer treatment method comprising administering an erb-family inhibitor and a raf and/or ras inhibitor
10/23/2003WO2003086466A1 Novel thrombomodulin expression promoters
10/23/2003WO2003086465A1 Drugs for myopia correction surgery
10/23/2003WO2003086464A1 Preventives/remedies for hotflash
10/23/2003WO2003086452A2 Methods of enhancing lysosomal storage disease therapy
10/23/2003WO2003086442A2 Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives
10/23/2003WO2003086440A1 Novel use of the extract of processed ginseng and saponin isolated therefrom
10/23/2003WO2003086439A1 Novel use of the extract of processed panax genus plant and saponin compound isolated therefrom
10/23/2003WO2003086438A1 Extract of processed panax genus plant, the preparation method thereof, and compositions containing the same
1 ... 5297 5298 5299 5300 5301 5302 5303 5304 5305 5306 5307 5308 5309 5310 5311 5312 5313 5314 5315 5316 5317 ... 7860